Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer
Veteran pharmaceutical executive to lead Tessera's next phase of growth as the company advances Gene Writing from platform innovation toward a broad clinical pipeline of genetic medicines SOMERVILLE, Mass., July 23, 2026 /PRNewswire/ -- Tessera Therapeutics ("Tessera"), the biotechnology...
Veteran pharmaceutical executive to lead Tessera's next phase of growth as the company advances Gene Writing from platform innovation toward a broad clinical pipeline of genetic medicines SOMERVILLE, Mass., July 23, 2026 /PRNewswire/ -- Tessera Therapeutics ("Tessera"), the biotechnology...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.